Natco Pharma Limited
Natco Pharma Limited lists 19 drug products in the FDA National Drug Code directory.
Products
| NDC | Product | Strength | Type |
|---|---|---|---|
| 63850-0010 | Anastrozole Tablet | Anastrozole 1 mg/1 | Rx |
| 63850-0107 | Everolimus Tablet | Everolimus 1 mg/1 | Rx |
| 63850-0064 | Everolimus Tablet | Everolimus .75 mg/1 | Rx |
| 63850-0063 | Everolimus Tablet | Everolimus .5 mg/1 | Rx |
| 63850-0058 | Everolimus Tablet | Everolimus 2.5 mg/1 | Rx |
| 63850-0059 | Everolimus Tablet | Everolimus 5 mg/1 | Rx |
| 63850-0060 | Everolimus Tablet | Everolimus 7.5 mg/1 | Rx |
| 63850-0061 | Everolimus Tablet | Everolimus 10 mg/1 | Rx |
| 63850-0062 | Everolimus Tablet | Everolimus .25 mg/1 | Rx |
| 63850-0005 | Granisetron hydrochloride Tablet, Film Coated | Granisetron Hydrochloride 1 mg/1 | Rx |
| 63850-0025 | Letrozole Tablet | Letrozole 2.5 mg/1 | Rx |
| 63850-0004 | Ondansetron Tablet, Film Coated | Ondansetron Hydrochloride 8 mg/1 | Rx |
| 63850-0003 | Ondansetron Tablet, Film Coated | Ondansetron Hydrochloride 4 mg/1 | Rx |
| 63850-0131 | Pomalidomide Capsule | Pomalidomide 1 mg/1 | Rx |
| 63850-0132 | Pomalidomide Capsule | Pomalidomide 2 mg/1 | Rx |
| 63850-0133 | Pomalidomide Capsule | Pomalidomide 3 mg/1 | Rx |
| 63850-0134 | Pomalidomide Capsule | Pomalidomide 4 mg/1 | Rx |
| 63850-0022 | Trihexyphenidyl Hydrochloride Tablet | Trihexyphenidyl Hydrochloride 5 mg/1 | Rx |
| 63850-0021 | Trihexyphenidyl Hydrochloride Tablet | Trihexyphenidyl Hydrochloride 2 mg/1 | Rx |
Recalls by Natco Pharma Limited
- D-0438-2024 Apr 17, 2024 · Class II
CGMP Deviations - D-0318-2024 Feb 14, 2024 · Class II
CGMP Deviations: Inadequate induction sealing on bottles, capsules were observed with bubbles on band seal, capsules with holes and spheres sticking to capsules. Also coding details were missing on…